Abstract: An exercise roller includes an elongated bar having grip handles arranged at opposing axial ends of the elongated bar, a cylindrical core supported by the elongated bar between the grip handles, and a cover that surrounds the cylindrical core and is formed of a material having a repeating pattern.

Abstract: Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as products containing such compounds, and methods of their use and synthesis. Such compounds have the structure of Formula (I) below: (I) or pharmaceutically acceptable salts thereof, wherein A, J, W1, Y, Z, R1, R2, R3 and R4 are as defined herein.

Abstract: An exercise roller includes an elongated bar having grip handles arranged at opposing axial ends of the elongated bar, a cylindrical core supported by the elongated bar between the grip handles, and a cover that surrounds the cylindrical core and is formed of a material having a repeating pattern.

Abstract: An exercise roller includes an elongated bar having grip handles arranged at opposing axial ends of the elongated bar, a cylindrical core supported by the elongated bar between the grip handles, and a cover that surrounds the cylindrical core and is formed of a material having a repeating pattern.

Abstract: Methods of calibrating strapdown heading sensors and strapdown heading sensors are provided. The methods include compensating raw sensor data generated by sensors of an uncalibrated strapdown heading sensor to compensate for errors in an instrument frame of the strapdown heading sensor. The strapdown heading sensor is put in a target apparatus and output data is compensated to compensate for errors in an apparatus frame relative to the instrument frame. The strapdown heading sensors include a housing and a compass module having a first sensor configured to detect a magnetic field of the Earth and a second sensor configured to detect a gravitational force of the Earth. The first sensor and the second sensor are each passively isolated from bending and/or flexing of the housing such that an alignment between the first sensor and the second sensor is not disturbed due to the bending and/or flexing.

Abstract: An attitude sensor system with automatic bias correction having a primary attitude sensor wherein the primary attitude sensor comprises at least one accelerometer and an auxiliary sensor system configured to automatically estimate a bias of the accelerometer of the primary attitude sensor such that the resulting error is removed from an output of the attitude sensor system.

Abstract: Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as products containing such compounds, and methods of their use and synthesis. Such compounds have the structure of Formula (I) below: (I) or pharmaceutically acceptable salts thereof, wherein A, J, W1, Y, Z, R1, R2, R3 and R4 are as defined herein.

Abstract: Methods of calibrating strapdown heading sensors and strapdown heading sensors are provided. The methods include compensating raw sensor data generated by sensors of an uncalibrated strapdown heading sensor to compensate for errors in an instrument frame of the strapdown heading sensor. The strapdown heading sensor is put in a target apparatus and output data is compensated to compensate for errors in an apparatus frame relative to the instrument frame. The strapdown heading sensors include a housing and a compass module having a first sensor configured to detect a magnetic field of the Earth and a second sensor configured to detect a gravitational force of the Earth. The first sensor and the second sensor are each passively isolated from bending and/or flexing of the housing such that an alignment between the first sensor and the second sensor is not disturbed due to the bending and/or flexing.

Abstract: Methods of calibrating strapdown heading sensors and strapdown heading sensors are provided. The methods include compensating raw sensor data generated by sensors of an uncalibrated strapdown heading sensor to compensate for errors in an instrument frame of the strapdown heading sensor. The strapdown heading sensor is put in a target apparatus and output data is compensated to compensate for errors in an apparatus frame relative to the instrument frame. The strapdown heading sensors include a housing and a compass module having a first sensor configured to detect a magnetic field of the Earth and a second sensor configured to detect a gravitational force of the Earth. The first sensor and the second sensor are each passively isolated from bending and/or flexing of the housing such that an alignment between the first sensor and the second sensor is not disturbed due to the bending and/or flexing.

Abstract: Methods of calibrating strapdown heading sensors and strapdown heading sensors are provided. The methods include compensating raw sensor data generated by sensors of an uncalibrated strapdown heading sensor to compensate for errors in an instrument frame of the strapdown heading sensor. The strapdown heading sensor is put in a target apparatus and output data is compensated to compensate for errors in an apparatus frame relative to the instrument frame. The strapdown heading sensors include a housing and a compass module having a first sensor configured to detect a magnetic field of the Earth and a second sensor configured to detect a gravitational force of the Earth. The first sensor and the second sensor are each passively isolated from bending and/or flexing of the housing such that an alignment between the first sensor and the second sensor is not disturbed due to the bending and/or flexing.

Abstract: An attitude sensor system with automatic bias correction having a primary attitude sensor wherein the primary attitude sensor comprises at least one accelerometer and an auxiliary sensor system configured to automatically estimate a bias of the accelerometer of the primary attitude sensor such that the resulting error is removed from an output of the attitude sensor system.

Abstract: Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where “” represents either or both the R and S form of the compound): where A, B, C, Y1, Y2, Z, R1, R2, R3, R4, R5, W1, n, p and q are as defined herein.

Abstract: A strapdown heading sensor includes an elongated housing and a compass module at least partially positioned within an inner cavity of the elongated housing. The compass module is cantilevered within the inner cavity of the elongated housing.

Abstract: Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where “” represents either or both the R and S form of the compound): where A, B, C, Y1, Y2, Z, R1, R2, R3, R4, R5, W1, n, p and q are as defined herein.

Abstract: An attitude sensor system with automatic bias correction having a primary attitude sensor wherein the primary attitude sensor comprises at least one accelerometer and an auxiliary sensor system configured to automatically estimate a bias of the accelerometer of the primary attitude sensor such that the resulting error is removed from an output of the attitude sensor system.

Abstract: Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where “” represents either or both the R and S form of the compound): where A, B, C, Y1, Y2, Z, R1, R2, R3, R4, R5, W1, n, p and q are as defined herein.

Abstract: Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36), GLP-1(9-36), and oxyntomodulin, or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where “” represents either or both the R and S form of the compound): where A, B, C, R1, R2, R3, R4, R5, n, p and q are as defined herein.

Abstract: Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where “” represents either or both the R and S form of the compound): where A, B, C, Y1, Y2, Z, R1, R2, R3, R4, R5, W1, n, p and q are as defined herein.

Abstract: Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where “” represents either or both the R and S form of the compound): where A, B, C, Y1, Y2, Z, R1, R2, R3, R4, R5, W1, n, p and q are as defined herein.

Abstract: Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36), GLP-1(9-36), and oxyntomodulin, or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where “” represents either or both the R and S form of the compound): where A, B, C, R1, R2, R3, R4, R5, n, p and q are as defined herein.